Search Results for 'prevalent disorder reaching epidemic'
2 results found.
Crospon gets FDA clearance for new product
A new product developed by a local medical device company will provide an improved diagnostic test for gastroesophageal reflux disease (GERD).
Local medical device developer secures additional €2m in funding
Local medical device developer Crospon has reason to celebrate on the double with the news that it has secured an additional €2 million in funding and that its flagship gastroenterology product has received clearance from the US Food and Drugs Administration.
